| |
| |
|
| Insider
Information: |
Sharp Philip A |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
738,118 |
|
|
Indirect Shares
|
440,231 |
|
|
| Direct
Value |
$106,532,330 |
|
|
|
Indirect Value
|
$39,819,819 |
|
|
| Total
Shares |
1,178,349 |
|
|
| Total
Value |
$146,352,148 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
Director |
2009-06-03 |
470,278 |
2003-11-12 |
0 |
Premium* |
|
|
Alnylam Pharmaceuticals Inc |
ALNY |
Director |
2024-02-29 |
0 |
2024-02-29 |
266,899 |
Premium* |
|
|
Syros Pharmaceuticals, Inc. |
SYRS |
Director |
2016-07-06 |
146,666 |
2016-07-06 |
40,000 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
2023-05-22 |
121,174 |
2023-05-22 |
133,332 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
86 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2014-10-13 |
4 |
AS |
$85.00 |
$9,350,000 |
D/D |
(110,000) |
74,996 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2019-04-15 |
4 |
AS |
$87.86 |
$1,323,442 |
D/D |
(15,000) |
235,633 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2019-11-18 |
4 |
AS |
$91.17 |
$1,375,662 |
D/D |
(15,000) |
235,633 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2015-12-04 |
4 |
AS |
$109.00 |
$3,270,000 |
D/D |
(30,000) |
140,795 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2020-11-25 |
4 |
AS |
$124.30 |
$3,746,749 |
D/D |
(30,000) |
235,633 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2018-03-09 |
4 |
AS |
$129.00 |
$1,935,000 |
D/D |
(15,000) |
140,795 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2020-02-12 |
4 |
AS |
$130.00 |
$3,900,000 |
D/D |
(30,000) |
235,633 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2018-03-13 |
4 |
AS |
$149.00 |
$2,235,000 |
D/D |
(15,000) |
140,795 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2022-02-09 |
4 |
AS |
$150.00 |
$4,500,000 |
D/D |
(30,000) |
0 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2024-02-29 |
4 |
AS |
$150.60 |
$4,540,071 |
D/D |
(30,000) |
0 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2022-08-15 |
4 |
AS |
$226.16 |
$7,760,736 |
D/D |
(33,670) |
0 |
0 |
% |
|
86 Records found
|
|
Page 4 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
